Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-α, and leukocyte arylsulfatase-A activity in patients with bladder cancer-Reference-Cited by-同舟云学术

Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-α, and leukocyte arylsulfatase-A activity in patients with bladder cancer

Published:2004-08 Issue:8 Volume:37 Page:673-678
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Koçak Hikmet,Öner-İyidoğan Yıldız,Koçak Taner,Öner Pernur

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference22 articles.

1. Arylsulfatase A activities in urine and tissues taken from bladder cancer patients;Mitsuhashi;Jpn. J. Exp. Med.,1984

2. Arylsulfatase A protein in sera of cancer patients;Honke;Cancer J.,1995

3. Arylsulfatase A in serum from patients with cancer of various organs;Laidler;Clin. Chim. Acta,1991

4. Lysosomal arylsulfatases of human leukocytes: increment of phosphorylated B variants in chronic myelogenous leukemia;Uehara;Cancer Res.,1983

5. Leukocyte arylsulfatase A activity in acute leukemia;Ömer;Cancer Biochem. Biophys.,1994

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective Assessment of Multiple Urinary Biomarkers to Diagnose Recurrence and Progression in Patients with Non‑muscle‑Invasive Bladder Cancer;Earth and Environmental Sciences Library;2024

2. Value of Immunological Biomarkers in Early Prediction of Bacillus Calmette-Guerin Failure in High-Risk Non-muscle-invasive Bladder Cancer;annals of urologic oncology;2023-10-05

3. Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging;BMC Medicine;2023-04-05

4. Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?;Frontiers in Molecular Biosciences;2023-01-09

5. The Interleukin-8 Pathway in Cancer;Cytokine and Chemokine Networks in Cancer;2023